Last updated: 9 July 2024 at 9:20am EST

Robert Duggan Net Worth




The estimated Net Worth of Robert W Duggan is at least $719 Million dollars as of 12 December 2023. Mr. Duggan owns over 17,999 units of Pulse Biosciences Inc stock worth over $633,908,828 and over the last 21 years he sold PLSE stock worth over $84,696,784. In addition, he makes $234,718 as Independent Chairman of the Board at Pulse Biosciences Inc.

Mr. Duggan PLSE stock SEC Form 4 insiders trading

Robert has made over 76 trades of the Pulse Biosciences Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently he bought 17,999 units of PLSE stock worth $164,691 on 12 December 2023.

The largest trade he's ever made was buying 376,489,880 units of Pulse Biosciences Inc stock on 6 March 2023 worth over $395,314,374. On average, Robert trades about 3,488,004 units every 45 days since 2003. As of 12 December 2023 he still owns at least 36,984,179 units of Pulse Biosciences Inc stock.

You can see the complete history of Mr. Duggan stock trades at the bottom of the page.





Robert Duggan biography

Robert W. Duggan serves as Independent Chairman of the Board of the Company. Mr. Duggan has been Chief Executive Officer of Duggan Investments, Inc., a venture capital and public equity investment firm primarily focused on patient-friendly breakthrough solutions to complex diseases of aging. From September 2007 through the acquisition by AbbVie Inc. in May 2015, Mr. Duggan was a member of the board of directors of Pharmacyclics, Inc., a patient-friendly, science-based, employee-driven developer of small-molecule medicines for the treatment of cancers. Mr. Duggan was also the Chairman and Chief Executive Officer of Pharmacyclics from September 2008 to May 2015 as well as its largest investor. From 1990 to 2003, Mr. Duggan was Chairman of the board of directors of Computer Motion, Inc. From 1997 to 2003, Mr. Duggan also served as Chief Executive Officer of Computer Motion. In June 2003, Computer Motion merged with Intuitive Surgical Inc. From 2003 to 2011, Mr. Duggan served on the board of directors of Intuitive Surgical. Since December 2019, Mr. Duggan has served on the board of directors of Summit Therapeutics plc and was appointed its Executive Chairman in February 2020. Mr. Duggan received a U.S. Congressman's Medal of Merit from Ron Paul in 1985 and in 2000 he was named a Knight of the Legion D’Honor by President Jacques Chirac of France. He is a member of the University of California at Santa Barbara Foundation board of trustees.

What is the salary of Robert Duggan?

As the Independent Chairman of the Board of Pulse Biosciences Inc, the total compensation of Robert Duggan at Pulse Biosciences Inc is $234,718. There are 8 executives at Pulse Biosciences Inc getting paid more, with Sandra Gardiner having the highest compensation of $2,097,570.



How old is Robert Duggan?

Robert Duggan is 75, he's been the Independent Chairman of the Board of Pulse Biosciences Inc since 2017. There are no older and 11 younger executives at Pulse Biosciences Inc.

What's Robert Duggan's mailing address?

Robert's mailing address filed with the SEC is 3957 POINT EDEN WAY, , HAYWARD, CA, 94545.

Insiders trading at Pulse Biosciences Inc

Over the last 8 years, insiders at Pulse Biosciences Inc have traded over $0 worth of Pulse Biosciences Inc stock and bought 18,070,761 units worth $194,618,110 . The most active insiders traders include Robert W Duggan, Mahkam Zanganeh, and Manmeet Singh Soni. On average, Pulse Biosciences Inc executives and independent directors trade stock every 52 days with the average trade being worth of $6,179,107. The most recent stock trade was executed by Burke Thomas Barrett on 20 May 2024, trading 10,000 units of PLSE stock currently worth $85,600.



What does Pulse Biosciences Inc do?

pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and



What does Pulse Biosciences Inc's logo look like?

Pulse Biosciences Inc logo

Complete history of Mr. Duggan stock trades at Intuitive Surgical Inc, Pulse Biosciences Inc, and Summit Therapeutics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
12 Dec 2023 Robert W Duggan
Director
Buy 17,999 $9.15 $164,691
12 Dec 2023
36,984,179
11 Dec 2023 Robert W Duggan
Director
Buy 90,118 $9.36 $843,504
11 Dec 2023
36,966,180
8 Dec 2023 Robert W Duggan
Director
Buy 116,656 $9.54 $1,112,898
8 Dec 2023
36,876,062
7 Dec 2023 Robert W Duggan
Director
Buy 74,852 $9.19 $687,890
7 Dec 2023
36,759,406
6 Dec 2023 Robert W Duggan
Director
Buy 82,813 $9.06 $750,286
6 Dec 2023
36,684,554
5 Dec 2023 Robert W Duggan
Director
Buy 66,021 $9.34 $616,636
5 Dec 2023
351,565
4 Dec 2023 Robert W Duggan
Director
Option 40,347 $10.66 $430,099
4 Dec 2023
36,591,808
1 Dec 2023 Robert W Duggan
Director
Buy 45,600 $9.07 $413,592
1 Dec 2023
258,544
30 Nov 2023 Robert W Duggan
Director
Buy 152,944 $9.06 $1,385,673
30 Nov 2023
212,944
29 Nov 2023 Robert W Duggan
Director
Buy 218,600 $9.38 $2,050,468
29 Nov 2023
60,000
28 Nov 2023 Robert W Duggan
Director
Buy 124,397 $8.98 $1,117,085
28 Nov 2023
36,391,194
17 Nov 2023 Robert W Duggan
Director
Buy 20,241 $6.10 $123,470
17 Nov 2023
36,266,797
7 Nov 2023 Robert W Duggan
Director
Option 13,265 $5.95 $78,927
7 Nov 2023
36,246,556
25 Aug 2023 Robert W Duggan
Director
Option 1,667 $5.95 $9,919
25 Aug 2023
36,233,291
25 Jul 2023 Robert W Duggan
Director
Option 1,667 $5.95 $9,919
25 Jul 2023
36,231,624
5 Jul 2023 Robert W Duggan
Director
Option 132,133 $2.19 $289,371
5 Jul 2023
36,229,957
9 May 2023 Robert W Duggan
Director
Buy 10,022,937 $6.51 $65,249,320
9 May 2023
30,414,661
30 Jun 2021 Robert W Duggan
Director
Buy 3,048,780 $16.40 $49,999,992
30 Jun 2021
14,708,561
11 May 2018 Robert W Duggan
Director
Buy 21,353 $23.16 $494,535
11 May 2018
5,862,422
13 Dec 2017 Robert W Duggan
Director
Buy 20,556 $22.44 $461,277
13 Dec 2017
5,841,069
19 Oct 2017 Robert W Duggan
Director
Buy 22,901 $22.79 $521,914
19 Oct 2017
5,820,513
24 Sep 2017 Robert W Duggan
Director
Buy 2,000,000 $15.02 $30,040,000
24 Sep 2017
5,797,612
14 Sep 2017 Robert W Duggan
Director
Buy 409,918 $14.36 $5,886,422
14 Sep 2017
3,797,612
1 Aug 2017 Robert W Duggan
Director
Buy 277,450 $23.14 $6,420,193
1 Aug 2017
3,387,694
22 May 2017 Robert W Duggan
Director
Buy 83,928 $26.86 $2,254,306
22 May 2017
3,110,244
9 May 2017 Robert W Duggan
Director
Buy 43,389 $21.04 $912,905
9 May 2017
3,026,316
28 Apr 2017 Robert W Duggan
Director
Buy 84,348 $23.88 $2,014,230
28 Apr 2017
35,000
25 Apr 2017 Robert W Duggan
Director
Buy 35,387 $24.79 $877,244
25 Apr 2017
2,933,579
17 Apr 2017 Robert W Duggan
Director
Buy 319,242 $24.45 $7,805,467
17 Apr 2017
2,898,192
6 Apr 2017 Robert W Duggan
Director
Buy 191,464 $19.75 $3,781,414
6 Apr 2017
2,578,950
16 Mar 2017 Robert W Duggan
Director
Buy 205,127 $23.56 $4,832,792
16 Mar 2017
2,378,486
9 Feb 2017 Robert W Duggan
Director
Buy 41,624 $11.64 $484,503
9 Feb 2017
2,173,359
6 Mar 2023 Robert W Duggan
Co-Chief Executive Officer
Buy 376,489,880 $1.05 $395,314,374
6 Mar 2023
552,354,161
16 Aug 2022 Robert W Duggan
Co-Chief Executive Officer
Buy 94,849,203 $0.97 $92,003,727
16 Aug 2022
162,532,792
12 May 2021 Robert W Duggan
Co-Chief Executive Officer
Buy 11,365,921 $5.24 $59,557,426
12 May 2021
67,662,454
6 Nov 2020 Robert W Duggan
Co-Chief Executive Officer
Buy 14,071,856 $3.34 $46,999,999
6 Nov 2020
56,296,533
18 May 2011 Robert W Duggan
Director
Option 1,000 $47.09 $47,090
18 May 2011
1,000
3 May 2011 Robert W Duggan
Director
Option 2,000 $47.09 $94,180
3 May 2011
2,000
6 Dec 2006 Robert W Duggan
Director
Option 12,998 $11.06 $143,758
6 Dec 2006
250,539
16 Nov 2006 Robert W Duggan
Director
Sale 57,389 $95.09 $5,457,120
16 Nov 2006
2,868
14 Nov 2006 Robert W Duggan
Director
Sale 231,111 $95.05 $21,967,101
14 Nov 2006
5,368
1 Nov 2006 Robert W Duggan
Director
Sale 110,000 $97.85 $10,763,500
1 Nov 2006
517,541
14 Sep 2006 Robert W Duggan
Director
Sale 50,000 $98.33 $4,916,500
14 Sep 2006
11,848
13 Jun 2006 Robert W Duggan
Director
Sale 11,239 $107.00 $1,202,573
13 Jun 2006
12,848
19 May 2006 Robert W Duggan
Director
Sale 700 $115.16 $80,612
19 May 2006
24,087
16 May 2006 Robert W Duggan
Director
Sale 1,385 $121.03 $167,627
16 May 2006
24,787
10 May 2006 Robert W Duggan
Director
Sale 55,600 $129.05 $7,175,180
10 May 2006
26,172
15 Feb 2006 Robert W Duggan
Director
Sale 31,000 $94.49 $2,929,190
15 Feb 2006
784,672
13 Dec 2005 Robert W Duggan
Director
Sale 4,100 $120.00 $492,000
13 Dec 2005
26,772
2 Dec 2005 Robert W Duggan
Director
Option 16,000 $2.53 $40,480
2 Dec 2005
895,214
26 Aug 2005 Robert W Duggan
Director
Sale 67,000 $72.26 $4,841,420
26 Aug 2005
815,884
25 Aug 2005 Robert W Duggan
Director
Sale 118,000 $76.66 $9,045,880
25 Aug 2005
882,884
25 Aug 2005 Robert W Duggan
Director
Sale 118,000 $76.66 $9,045,880
25 Aug 2005
882,884
1 Aug 2005 Robert W Duggan
Director
Sale 4,091 $67.62 $276,633
1 Aug 2005
26,872
1 Aug 2005 Robert W Duggan
Director
Sale 2,609 $67.60 $176,368
1 Aug 2005
30,963
1 Aug 2005 Robert W Duggan
Director
Sale 36,835 $67.62 $2,490,783
1 Aug 2005
1,015,884
1 Aug 2005 Robert W Duggan
Director
Sale 23,165 $67.60 $1,565,954
1 Aug 2005
1,052,719


Pulse Biosciences Inc executives and stock owners

Pulse Biosciences Inc executives and other stock owners filed with the SEC include: